Waters Q1 sales down 1% to $685M, non-GAAP EPS $2.49; guides FY organic growth 3-5%

WATERS CORP /DE/

2023-Q1 EPS reported $2.38 revenue$684,674,000

Q1 sales $685M (-1% reported, +3% constant currency); GAAP EPS $2.38, non-GAAP EPS $2.49, both down YoY.
Pharma sales -4% constant currency; recurring revenues +8% constant currency driven by service and chemistries.
FY2023 guidance: organic constant currency growth 3-5%; non-GAAP EPS $12.55-$12.75, including ~1% FX headwind.
Q2 2023 guidance: organic CC growth 1-3%; non-GAAP EPS $2.52-$2.62, with ~1% FX and ~3% Wyatt dilution.
Pending Wyatt Technology acquisition expected to close Q2 2023, adding ~2.5% to FY reported sales; accretive Q1 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

WATERS CORP /DE/ reported first quarter of 2023 results: revenue $685 million, EPS $2.38 per diluted share.

Period: first quarter of 2023
Revenue: $685 million
EPS: $2.38 per diluted share
Result: reported results

Exact text from the filing

Waters Corporation (NYSE: WAT) today announced its financial results for the first quarter of 2023. Sales for the first quarter of 2023 were $685 million, a decrease of 1% as reported and an increase of 3% in constant currency, compared to sales of $691 million for the first quarter of 2022. On a GAAP basis, diluted earnings per share (EPS) for the first quarter of 2023 decreased to $2.38, compared to $2.62 for the first quarter of 2022.

View on SEC.gov

Browse all earnings releases →

WATERS CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-23-138873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.